Pioglitazone trial for NASH: results show promise.
Lang
Les
L
D031204:Caloric Restriction; D003131:Combined Modality Therapy; D005234:Fatty Liver / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy* / Q000473:pathology; D006505:Hepatitis / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000473:pathology; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D012107:Research Design; D045162:Thiazolidinediones / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone